Hyperlipoproteinemia type I

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is hyperlipoproteinemia type I?

Hyperlipoproteinemia type I is a rare inherited condition caused by lipoprotein lipase (LPL) deficiency that results in the impairment of the breakdown of fat. With LPL deficiency, triglycerides accumulate and may lead to other conditions, e.g. enlarged spleen/liver, pancreatitis, and skin lesions.

Common symptoms reported by people with hyperlipoproteinemia type I

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people with hyperlipoproteinemia type I

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Subutex)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)
Treatment name(s)

(BuTrans Transdermal Patch)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)
Treatment name(s)

(Neurontin)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)
Treatment name(s)

(Ultram)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)

Data from patients with hyperlipoproteinemia type I, who reported starting treatments within the last 5 years.
Last updated:

Compare treatments taken by people with hyperlipoproteinemia type I

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Subutex)
Perceived effectiveness
for pain (1 evaluation)
Side effects
Total evaluations
1
Tried for
pain (1)
Treatment name(s)

(BuTrans Transdermal Patch)
Perceived effectiveness
for pain (2 evaluations)
Side effects
lethargy
Total evaluations
2
Tried for
pain (1)
Treatment name(s)

(Neurontin)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
pain (1)
Treatment name(s)

(Ultram)
Perceived effectiveness
for pain (1 evaluation)
Side effects
visual hallucinations
Total evaluations
1
Tried for
pain (1)
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with hyperlipoproteinemia type I, who reported starting treatments within the last 5 years.
Last updated:

Who has hyperlipoproteinemia type I on PatientsLikeMe?


Age
Age Proportion # of patients
<20 0
20s 2
30s 2
40s 1
50s 4
60s 2
70+ 1
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 3
20-29 years 0
30-39 years 0
40-49 years 1
50-59 years 0
60-69 years 0
70+ years 0

Sex

Distribution of sex

75% Female
25% Male

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 7
Not Diagnosed 1

These charts show data from hyperlipoproteinemia type I patients who have completed their condition history
Last updated: